Keywords: sirolimus, impresses, ph, wet, amd, trial, macusight

Sirolimus impresses in Ph I wet AMD trial

Article | 03 March 2008

Print This

MacuSight, a USA-based developer of therapeutics for the treatment of severe ocular conditions, says that it has seen positive data ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in